SMS Pharmaceuticals Ltd (SMSPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 517655, "name": "SMS Pharma.", "stock_name": "SMS Pharma.", "full_name": "SMS Pharmaceuticals Ltd", "name_url": "stocks-analysis/sms-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "378.10", "chg": -6.35, "chgp": "-1.65%", "dir": -1, "prev_price": "384.45", "mcapval": "3,622.00 Cr", "mcap": "Small Cap", "scripcode": 532815, "symbol": "SMSPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE812G01025", "curr_date": "Jun 15, 03:30 PM", "curr_time": "20:43 PM", "last_traded_at": "Jun 15, 03:30 PM IST", "bse_nse_vol": "1.12 lacs", "exc_status": "Active", "traded_date": "Jun 15, 2026", "traded_date_str": "2026 06 15", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-risk-amid-strong-returns-4045705", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_valuationdot_4045705.png", "date": "2026-06-11 08:00:33", "description": "SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that have significantly outpaced the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics, compares them with peer averages, and assesses the implications for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "SMS Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4037585", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4037585.png", "date": "2026-06-07 10:10:20", "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "SMS Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4037669", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4037669.png", "date": "2026-06-06 10:10:19", "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "SMS Pharmaceuticals Ltd Falls 3.02%: Quality and Valuation Concerns Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-falls-302-quality-and-valuation-concerns-weigh-on-stock-4023468", "imagepath": "", "date": "2026-05-30 17:06:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Sharp 10.54% intraday price drop to Rs.381.20 amid mixed technical signals</p>\n <p><strong>25 May:</strong> Valuation grade shifts from very expensive to expensive</p>\n <p><strong>26 May:</strong> Quality grade downgraded from Hold to Sell; stock closes at Rs.370.25 (-2.87%)</p>\n <p><strong>26 May:</strong> MarketsMOJO downgrades SMS Pharmaceuticals Ltd to Sell rating</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.381.20</div></div>\n <div class=\"stat-item\"><div ..." }, { "title": "MarketsMOJO Downgrades SMS Pharmaceuticals Ltd to Sell Amid Valuation and Quality Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-downgrades-sms-pharmaceuticals-ltd-to-sell-amid-valuation-and-quality-concerns-4012858", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_mojoScore_4012858.png", "date": "2026-05-26 08:11:03", "description": "SMS Pharmaceuticals Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, stretched valuations, and mixed technical signals, despite the company’s strong stock returns over recent years." }, { "title": "SMS Pharmaceuticals Ltd Downgraded as Quality Parameters Deteriorate Amid Mixed Financial Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-downgraded-as-quality-parameters-deteriorate-amid-mixed-financial-performance-4012300", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_qualitydot_4012300.png", "date": "2026-05-26 08:00:12", "description": "SMS Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality rating downgraded from Hold to Sell by MarketsMOJO as of 25 May 2026. This shift reflects a notable deterioration in key business fundamentals including return ratios, debt levels, and growth consistency, raising concerns about the company’s medium-term prospects despite its strong stock price performance relative to the Sensex over recent years." }, { "title": "SMS Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4009874", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_technicaldot_4009874.png", "date": "2026-05-25 08:01:21", "description": "SMS Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, despite a sharp 10.54% decline in its share price on 25 May 2026. This article analyses the recent technical indicator signals, price action, and relative performance against the Sensex to provide a comprehensive view of the stock’s current market positioning." }, { "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-4009783", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SMSPharmaceutic_valuationdot_4009783.png", "date": "2026-05-25 08:00:31", "description": "SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration of price attractiveness in the Pharmaceuticals & Biotechnology sector. Despite a recent sharp decline in share price, the company’s fundamentals and relative valuation metrics suggest a nuanced investment case amid broader market and sector trends." }, { "title": "Are SMS Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-sms-pharmaceuticals-ltd-latest-results-good-or-bad-4008898", "imagepath": "", "date": "2026-05-23 19:18:53", "description": "SMS Pharmaceuticals Ltd reported its financial results for Q4 FY26, showcasing a mixed performance. The company achieved net sales of ₹237.95 crores, reflecting a sequential growth of 13.07% from ₹210.45 crores in the previous quarter, although this represents a decline of 4.13% compared to ₹248.20 crores in Q4 FY25. The consolidated net profit for the quarter surged to ₹32.71 crores, indicating a significant quarter-on-quarter increase of 39.37% from ₹23.47 crores, and a year-on-year growth of 60.97%.\n\nHowever, the operating margin experienced a contraction, falling to 16.77% from 20.74% in the previous quarter, marking the weakest performance in three quarters. This decline in margins is attributed to a notable 40% increase in employee costs, which rose to ₹29.47 crores from ₹21.05 crores in Q3 FY26. The profit after tax margin also compressed to 8.81% from 11.02% in the previous quarter.\n\nFor the full fi..." } ], "total": 768, "sid": "517655", "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655" }, "announcements": [ { "caption": "Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015.", "datetime": "05-Jun-2026", "details": "Please find the annexure", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "30-May-2026", "details": "Transcripts of the Conference call held on 27th May 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "27-May-2026", "details": "Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and year ended 31st March 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25", "dt": "2025-09-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15", "dt": "2015-12-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Sharp 10.54% intraday price drop to Rs.381.20 amid mixed technical signals

25 May: Valuation grade shifts from very expensive to expensive

26 May: Quality grade downgraded from Hold to Sell; stock closes at Rs.370.25 (-2.87%)

26 May: MarketsMOJO downgrades SMS Pharmaceuticals Ltd to Sell rating

Week Open

Rs.381.20

Read full news article

MarketsMOJO Downgrades SMS Pharmaceuticals Ltd to Sell Amid Valuation and Quality Concerns

2026-05-26 08:11:03

SMS Pharmaceuticals Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, stretched valuations, and mixed technical signals, despite the company’s strong stock returns over recent years.

Read full news article

SMS Pharmaceuticals Ltd Downgraded as Quality Parameters Deteriorate Amid Mixed Financial Performance

2026-05-26 08:00:12

SMS Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality rating downgraded from Hold to Sell by MarketsMOJO as of 25 May 2026. This shift reflects a notable deterioration in key business fundamentals including return ratios, debt levels, and growth consistency, raising concerns about the company’s medium-term prospects despite its strong stock price performance relative to the Sensex over recent years.

Read full news article

SMS Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-25 08:01:21

SMS Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, despite a sharp 10.54% decline in its share price on 25 May 2026. This article analyses the recent technical indicator signals, price action, and relative performance against the Sensex to provide a comprehensive view of the stock’s current market positioning.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Signal Changing Price Attractiveness

2026-05-25 08:00:31

SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration of price attractiveness in the Pharmaceuticals & Biotechnology sector. Despite a recent sharp decline in share price, the company’s fundamentals and relative valuation metrics suggest a nuanced investment case amid broader market and sector trends.

Read full news article

Are SMS Pharmaceuticals Ltd latest results good or bad?

2026-05-23 19:18:53

SMS Pharmaceuticals Ltd reported its financial results for Q4 FY26, showcasing a mixed performance. The company achieved net sales of ₹237.95 crores, reflecting a sequential growth of 13.07% from ₹210.45 crores in the previous quarter, although this represents a decline of 4.13% compared to ₹248.20 crores in Q4 FY25. The consolidated net profit for the quarter surged to ₹32.71 crores, indicating a significant quarter-on-quarter increase of 39.37% from ₹23.47 crores, and a year-on-year growth of 60.97%. However, the operating margin experienced a contraction, falling to 16.77% from 20.74% in the previous quarter, marking the weakest performance in three quarters. This decline in margins is attributed to a notable 40% increase in employee costs, which rose to ₹29.47 crores from ₹21.05 crores in Q3 FY26. The profit after tax margin also compressed to 8.81% from 11.02% in the previous quarter. For the full fi...

Read full news article